Celldex Therapeutics: The Losing Streak Continues (CLDX)

Celldex Therapeutics (NASDAQ:CLDX) traded today at a new 52-week low of $6.67. Approximately 2.1 million shares have changed hands today, as compared to an average 30-day volume of 2.6...